12:00 AM
Oct 20, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

RhPSA prostate cancer vaccine: Phase I/II started

Cyto Pulse began a Swedish Phase I/II trial to evaluate intradermal pVAXrcPSAv53l in combination with electroporation in 18 patients for...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >